Wonkwang University Hospital
Iksan, Muwangro 895, 54538, South Korea
NCT Number: NCT05842408
This study is to evaluate efficacy and safety of DA-5212 in patients with functional dyspepsia
Looking for future studies?
Notify Me19 year and older
All sexes
Interventional
Phase 3
Iksan, Muwangro 895, 54538, South Korea
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Test drug: DA-5212
Control drug: DA-5212-R
Time frame: Change from baseline at 4 weeks
Time frame: Change from baseline at 4 weeks
Dong-A ST Co., Ltd.
Industry
A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of DA-5212 in Patients with Functional Dyspepsia
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06732453
Digestive System Diseases, Functional Dyspepsia
Charlotte, North Carolina, United States
View Trial DetailsNCT04526119
Functional Dyspepsia
Matsumoto, Nagano, Japan
View Trial DetailsNCT05513040
Functional Dyspepsia
Lanzhou, Gansu, China
View Trial DetailsNCT03176927
Chronic Nausea, Diabetic Gastroparesis
Nashville, Tennessee, United States
View Trial Details